{"nct_id":"NCT03553836","title":"Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2018-09-12","start_date_type":"ACTUAL","primary_completion_date":"2021-06-21","primary_completion_date_type":"ACTUAL","completion_date":"2033-10-12","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}